Abstract |
ONO-1301, a synthetic prostacyclin agonist with thromboxane synthase inhibitory activity, promotes the production of hepatocyte growth factor (HGF) and vascular endothelial growth factor ( VEGF) by various cell types. Here, we evaluated the therapeutic efficacy of ONO-1301 in rats with ischemia/reperfusion injury. Ligation of the left anterior descending arteries was performed in 10-week-old Wistar rats, and released 30 min later. A slow-release form of ONO-1301 was administered subcutaneously at 3h and 3 weeks after reperfusion injury. Hemodynamic parameters were significantly improved in the ONO-1301 group. Histological analysis revealed that ONO-1301 suppressed ischemic and fibrotic changes in the myocardium (ischemic area, control group: 58.6 ± 8.7% vs. ONO-1301 group: 44.4 ± 5.8%, fibrotic area, 33.5 ± 5.9% vs. 22.3 ± 6.2%, P<0.05, respectively), and enhanced neovascularization in the border zone. HGF expression was up-regulated by ONO-1301. Double-immunostaining revealed that myofibroblasts in the border zone of ischemic myocardium mainly expressed HGF. Our findings suggest that ONO-1301 might have therapeutic potential in treating ischemic heart disease.
|
Authors | Yoichiro Hirata, Michio Shimabukuro, Etsuko Uematsu, Takeshi Soeki, Hirotsugu Yamada, Yoshiki Sakai, Mizuho Nakayama, Kunio Matsumoto, Takashi Igarashi, Masataka Sata |
Journal | European journal of pharmacology
(Eur J Pharmacol)
Vol. 674
Issue 2-3
Pg. 352-8
(Jan 15 2012)
ISSN: 1879-0712 [Electronic] Netherlands |
PMID | 22094066
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 Elsevier B.V. All rights reserved. |
Chemical References |
- Delayed-Action Preparations
- Enzyme Inhibitors
- Pyridines
- ONO 1301
- Hepatocyte Growth Factor
- Epoprostenol
- Thromboxane-A Synthase
|
Topics |
- Animals
- Delayed-Action Preparations
- Enzyme Inhibitors
(chemical synthesis, pharmacology, therapeutic use)
- Epoprostenol
(agonists)
- Fibrosis
- Heart
(drug effects, physiopathology)
- Hepatocyte Growth Factor
(metabolism)
- Male
- Myocardium
(metabolism, pathology)
- Neovascularization, Physiologic
(drug effects)
- Pyridines
(chemical synthesis, pharmacology, therapeutic use)
- Rats
- Rats, Wistar
- Reperfusion Injury
(metabolism, pathology, physiopathology, prevention & control)
- Thromboxane-A Synthase
(antagonists & inhibitors)
|